INTECH Investment Management’s Avanos Medical AVNS Stock Holding History

INTECH Investment Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$217K	Sell	8,731 -114,423	-93%	-$2.68M	﹤0.01%	1755
2026 Q1	$1.73M	Buy	123,154 +102,527	+497%	+$1.38M	0.02%	768
2025 Q4	$232K	Sell	20,627 -5,672	-22%	-$64.9K	﹤0.01%	1899
2025 Q3	$304K	Hold	26,299	–	–	﹤0.01%	1815
2025 Q2	$322K	Sell	26,299 -97,762	-79%	-$1.23M	﹤0.01%	1830
2025 Q1	$1.78M	Buy	124,061 +75,279	+154%	+$1.18M	0.02%	829
2024 Q4	$777K	Buy	48,782 +40,186	+467%	+$795K	0.01%	1305
2024 Q3	$207K	Buy	+8,596	New	+$196K	﹤0.01%	1703

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

INTECH Investment Management's AVNS Position: Q2 2026 in Review

INTECH Investment Management reduced its Avanos Medical (AVNS) stake by 93% in Q2 2026, selling an estimated $2.68M and leaving 8,731 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #1755.

INTECH Investment Management first reported a position in AVNS in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.78M in Q1 2025. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

INTECH Investment Management held 8,731 shares of Avanos Medical worth $217K as of Q2 2026.
INTECH Investment Management sold 114,423 Avanos Medical shares in Q2 2026, an estimated $2.68M.
Avanos Medical made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1755 holding.
INTECH Investment Management first reported a position in Avanos Medical in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Avanos Medical position peaked at $1.78M in Q1 2025.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.